B. Braun receives FDA approval for Florida pharmaceutical manufacturing plant

January 28, 2022 By Sean Whooley

B. Braun’s new Daytona Beach, Florida manufacturing plant. [Image from B. Braun]

B. Braun Medical announced today that it received final approval from the FDA for its new pharmaceutical manufacturing plant.

Bethlehem, Pennsylvania–based B. Braun Medical’s Daytona Beach, Florida–based plant will produce 0.9% sodium chloride for injection available in B. Braun’s Excel Plus IV bags in 1,000 ml and 500 ml sizes.

Get the full story at our sister site, Pharmaceutical Processing World.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.